Marek David C 4
4 · Myovant Sciences Ltd. · Filed Apr 19, 2022
Insider Transaction Report
Form 4
Marek David C
DirectorPrincipal Executive Officer
Transactions
- Award
Common Shares
2022-04-15+134,567→ 472,550 total - Award
Stock Option (Right to Buy)
2022-04-15+204,808→ 204,808 totalExercise: $11.33Exp: 2032-04-14→ Common Shares (204,808 underlying)
Footnotes (2)
- [F1]The Common Shares are to be acquired upon the vesting of certain Restricted Stock Units ("RSUs") granted to the Reporting Person. 1/4 of the common shares underlying the RSUs vest on April 15, 2023, and 1/16 of the common shares underlying the RSUs vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date.
- [F2]1/4 of the common shares underlying this option vest on April 15, 2023, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date.